Global Pharma Guidance Tracker – October 2022
Executive Summary
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
You may also be interested in...
Saudi FDA Finalizes Approach To Commercial Info In Public Assessment Reports
Saudi Arabia has explained what information on a drug’s review will be made public following a marketing authorization decision.
EU Finalizes Option To Omit Expiry Date On Inner Labeling Of Investigational Drugs
Revised labeling requirements for unauthorized investigational and auxiliary medicinal products under the EU Clinical Trial Regulation have been published in the Official Journal.
EMA Launches First RWE Studies Under Big Data Project
The European Medicines Agency has partnered with eight institutions having access to real-world healthcare data to enable its DARWIN EU project to deliver real-world evidence to the EU medicines regulatory network when needed.